Overview A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis Status: Recruiting Trial end date: 2022-06-30 Target enrollment: Participant gender: Summary The aim of the investigators study was to investigate the safety and efficacy of autologous ADSCs for the clinical treatment of liver cirrhosis. Phase: Phase 2 Details Lead Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.